Fernandina Beach, FL – January 24, 2025 – GalenusRx, a leader in innovative medication management solutions, is pleased to announce the appointment of Sandra Gomberg, DNP, RN, to its Advisory Board. Dr. Gomberg brings over three decades of experience in healthcare leadership and a proven track record of driving disruptive innovation in health care delivery.
Dr. Gomberg has held numerous executive roles, including President of Aria Jefferson Health System and Chief Executive Officer of Temple University Hospital Inc. Her extensive background in improving access to quality, equitable healthcare and her expertise in governance and leadership will be invaluable to GalenusRx as the company continues to expand its impact in the healthcare industry.
Peter Panageas, Chief Commercial Officer of GalenusRx, commented: “We are thrilled to welcome Sandra Gomberg to our Advisory Board. Her deep understanding of healthcare systems and her commitment to innovation align perfectly with our mission at GalenusRx. Sandra’s insights and leadership will be instrumental as we continue to enhance our medication management solutions and improve patient outcomes.”
Dr. Gomberg’s appointment reflects GalenusRx’s ongoing commitment to assembling a diverse and experienced team to guide the company’s strategic direction and growth. Her addition to the Advisory Board is expected to further strengthen GalenusRx’s position as a leader in the healthcare industry. Dr. Gomberg commented: “I am honored to join the GalenusRx Advisory Board. I look forward to collaborating with such a talented team to advance our shared goal of improving medication safety and patient outcomes. Together, we can make a meaningful impact on the healthcare industry.”
